Is Santen Pharmaceutical stock a buy?
What Is The Conclusion?
Right now our advanced algorithms say:
Do the analyst corps agree?
Interesting Questions and Easy Answers!
Yes, Santen Pharmaceutical pays dividends. Last time was Sunday 1st of December 2024 where the investors holding the stock on Friday 27th of September 2024 were paid $0.11849 per share. Over the last 26 times between 2011 and 2024, Santen Pharmaceutical has paid $231.50589 with an average of $8.9 per share.
Sorry, we do not have any analyst data for this ticker
We cannot find data for Santen Pharmaceutical 10 years ago, but if you had invested on Monday 9th of September 2019 when the price was $16.52, you would have made a loss of $-4.98 per share or -30.15%
No, the average daily trading liquidity for Santen Pharmaceutical is $553 thousand. Trading in stocks with this little trading liquidity is very dangerous, and you can get into a situation where it will be hard to trade your stocks. In addition, these types of stocks usually have very high volatility.
Santen Pharmaceutical has no real debt, which is good in periods of high inflation. Santen Pharmaceutical has a good net profit margin of 8.82% and should have high tolerances against inflation.
We have calculated the inflation risk for Santen Pharmaceutical to be low [0.4 of 1]
US inflation for July 2024 was 0.15%. Over the last 12 months, the US inflation is 2.92%. The 10-year treasury yield that indicates the future interest level is currently 3.72 and is down -0.95 over the last 30 days.